The substance is a biologic response modifier. It is prepared from cultures of genetically modified Escherichia coli using recombinant DNA technology.
Anakinra blocks the biologic activity of naturally occuring IL-1, including inflammation and cartilage degradation associated with rheumatoid arthritis, by competetively inhibiting the binding of IL-1 to the Interleukin-1 type receptor, which is expressed in many tissues and organs. IL-1 is produced in response to inflammatory stimuli and mediates various physiologic responses, including inflammatory and immunologic reactions. IL-1 additionally stimulates bone resorption and induces tissue damage like cartilage degradation as a result of loss of proteoglycans. In patients with rheumatoid arthritis the natural IL-1 receptor antagonist is not found in effective concentrations in synovium and synovial fluid to counteract the elevated IL-1 concentrations in these patients.
More on [ Anakinra ]

Anakinra ( Kineret ) - Patient and physician information for this medication, which is used to relieve pain and swelling caused by rheumatoid arthritis.
MedlinePlus: Anakinra - Features information about dosage, usage, warnings, and side effects.
Meta Description: [ Anakinra ]